ZTS
NYSE · Pharmaceuticals
Zoetis Inc
$76.68
+2.29 (+3.07%)
ZTS News2 articles
Zoetis Shares Tumble After Pet Care Sales Slump, Guidance Cut
Zoetis lowered its 2026 revenue and profit forecasts after U.S. pet product sales dropped 11% in Q1, missing analyst estimates and sending shares down 21%.
Zoetis Shares Plunge 20% on Weak Pet Owner Spending, Lowered Guidance
Zoetis shares plunged 20% after cutting its 2026 outlook and missing Q1 estimates, as U.S. pet owners cut back on vet visits and premium treatments, intensifying competition.